Yet another PR...... First Patient Treated with
Post# of 148150
(Total Views: 479)
Posted On: 04/15/2020 6:15:40 AM
Yet another PR......
First Patient Treated with Leronlimab in Phase 2b/3 Trial for COVID-19
Download as PDFApril 15, 2020 6:15am EDT
The Company’s Phase 2b/3 trial is for patients with severe and critically ill COVID-19 indications. Interim analysis will be conducted after results for first 50 patients are available.
https://www.cytodyn.com/newsroom/press-releas...-2b3-trial
First Patient Treated with Leronlimab in Phase 2b/3 Trial for COVID-19
Download as PDFApril 15, 2020 6:15am EDT
The Company’s Phase 2b/3 trial is for patients with severe and critically ill COVID-19 indications. Interim analysis will be conducted after results for first 50 patients are available.
https://www.cytodyn.com/newsroom/press-releas...-2b3-trial
(3)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼